Chicago, Illinois, June 8, 2018 – XMS Capital Partners, LLC (“XMS”) has announced that it served as financial advisor to Exact Sciences in connection with Exact’s public offering of 1.0% Convertible Senior Notes. XMS is proud to have served as financial advisor to Exact Sciences in every capital raise since 2009, a period in which Exact’s market capitalization has grown from less than $30 million to $7.5 billion.

Exact Sciences Corporation (NASDAQ: EXAS) has priced its underwritten public offering of 1.0% Convertible Senior Notes due 2025 (the “Notes”) and upsized the offering from $150 million to $190 million aggregate principal amount, providing for total gross proceeds of $202.4 million, excluding accrued interest. The initial public offering price for the Notes will be 106.5% of face value plus accrued interest from January 17, 2018. The Notes issuance is a reopening of, and will be fully fungible and form a single series with, the $690 million aggregate principal amount of the Company’s 1.0% Convertible Senior Notes Due 2025 issued by the Company on January 17, 2018 and will have the same CUSIP number. The Company has granted the underwriters a 30-day option to purchase up to an additional $28.5 million aggregate principal amount of the Notes at the public offering price, less the underwriting discount, plus accrued interest.

About Exact Sciences Corporation

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.

About XMS Capital Partners

XMS Capital Partners, established in 2006, is a global, independent financial services firm providing investment banking, asset management and merchant banking services to clients. It has offices in Chicago, London and Dublin.

XMS provides Involvement BankingTM, which goes beyond transaction oriented investment banking and focuses on delivering objective, value added advice and custom tailored solutions to help clients achieve their strategic goals. It consistently creates value for its clients by giving them access to comprehensive, independent M&A, strategic advisory, financial restructuring, capital structure advisory and private capital advisory expertise.
XMS Capital Partners, LLC is a FINRA member and SIPC member. For more information, please visit www.xmscapital.com.

Media Contact:

Hank Hakewill, Hakewill & Associates

Phone: 847-256-5420 (office); 847-714-6561 (cell)
Email: hankhake@yahoo.com